Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma

Overview of attention for article published in Frontiers in Pharmacology, July 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (65th percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 6,699 followers.

New Research: Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma https://t.co/OYgjOGFKP4 #pharmacology

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.